(Q51533207)

6 April 2018

reason for preferred rank

title

Peptides associated with hyperphagia in adults with Prader–Willi syndrome before and during GH treatment (English)

1 reference

https://api.crossref.org/works/10.1016/S1096-6374(03)00077-7

3 April 2024

Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624765

3 April 2024

main subject

Prader–Willi syndrome

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1096-6374(03)00077-7

3 April 2024

4

Maria Petersson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624765

3 April 2024

author name string

Charlotte Höybye

1

1 reference

6 April 2018

Britta Barkeling

2

1 reference

6 April 2018

Ulrick Espelund

3

1 reference

6 April 2018

Marja Thorén

5

1 reference

6 April 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14624765

3 April 2024

publication date

1 December 2003

1 reference

6 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S1096637403000777?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1096-6374(03)00077-7

https://api.elsevier.com/content/article/PII:S1096637403000777?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/S1096-6374(03)00077-7

Growth Hormone & I G F Research

3 April 2024

published in

1 reference

6 April 2018

volume

13

1 reference

6 April 2018

issue

6

1 reference

6 April 2018

page(s)

322-327

1 reference

6 April 2018

Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Growth hormone treatment improves body composition in adults with Prader–Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Ghrelin enhances appetite and increases food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Elevated plasma ghrelin levels in Prader–Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Diagnosis of the Prader-Willi syndrome by proving the absence of the unmethylated PW71 DNA fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Long-term changes in gastrin, cholecystokinin and insulin in response to oxytocin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Circulating ghrelin levels are decreased in human obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900077-7

7 January 2021

Elevated plasma levels of oxytocin in obese subjects before and after gastric banding

19

1 reference

https://api.crossref.org/works/10.1016/S1096-6374(03)00077-7

3 April 2024

Identifiers

1 reference

6 April 2018

1 reference

6 April 2018